Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Metso Outotec launches their next-generation Metrics solution for improved equipment performance and plant availability in the aggregates industry

Metso Outotec Corporation’s press release on April 29, 2022, at 09:00 a.m. EESTMetso Outotec is launching an upgraded version of Metrics, an innovative cloud-based tool for real-time monitoring for aggregates customers’ Lokotrack mobile crushers and screens. The new remote monitoring solution will bring significantly better connectivity and optimization benefits to aggregate customers’ crushing processes. The solution has been developed together with distributors and customers and offers several state-of-the-art features supporting customers to achieve their sustainability and operational

Axolot Solutions Holding AB (publ) - Interim report January-March 2022

THE LAUNCH OF HIGHLY EFFICIENT AXOPUR[®] 2.0 OPENS UP NEW MARKETSSummary of the first quarter 2022 Financially · Net sales amounted to 528 tSEK (483 tSEK for the corresponding quarter in 2021), which refers to customer trial activities and studies. · Other revenues were 1 tSEK (190), where the revenue in the comparison period relates to public research grants and project support. · Earnings before interest and tax became -4 104 tSEK (-4 445). · Net earnings per share amounted to -0,08 SEK (-0,10). · Liquid funds were 8 773 tSEK at the end of the first quarter 2022. In

Electrolux Q1 2022 Interim report: Consistent execution in a challenging environment

Highlights of the first quarter of 2022 · Net sales increased to SEK 30,118m (29,026), corresponding to an organic sales decline of 3.4%. This was driven by lower volumes compared to a strong last year, partially offset by strong price execution. · Operating income amounted to SEK 1,575m (2,297), corresponding to a margin of 5.2% (7.9). · Operating income includes a positive non-recurring item of SEK 656m, related to the U.S. tariff case, impacting the business area North America. Excluding this non-recurring item, operating income amounted to SEK 919m, corresponding to a margin

Minutes from the Annual General Meeting 2022 in Genetic Analysis AS

Oslo, Norway, April 29, 2022 - Genetic Analysis AS (the "Company", Ticker: GEAN) held its Annual General Meeting on April 28 at 15:00 hours (CET) on the Company's premises in Kabelgata 8, Oslo.The agenda for the meeting was as follows: 1. Election of a chairperson and a person to co-sign the minutes Kathryn M. Baker was elected to chair the general meeting. The Chairperson ascertained the lawfulness of the general meeting. Eilert Aamodt was elected to co-sign the minutes. 2. Approval of the annual accounts and directors’ report of Genetic Analysis AS for 2021, including allocation

WELCOME TO THE EQT AB ANNUAL SHAREHOLDERS’ MEETING 2022

The shareholders of EQT AB (publ) (“EQT”) are given notice of the Annual Shareholders’ Meeting (the “Meeting”) to be held on Wednesday 1 June 2022 at 16.00 CEST. EQT’s registration number is 556849-4180, and its registered office is in Stockholm, Sweden.Conditions for participation Shareholders who wish to participate in the Meeting must be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”) concerning to the circumstances on Monday 23 May 2022. In addition, the shareholders must give notice of their participation in the Meeting: · Shareholders who

Careium reports first quarter results 2022

The quarter in summary · Careium’s net sales amounted to SEK 178.5 million (138.0), an increase of 29.4 percent. Service sales amounted to 139.4 million (112.6) an increase of 23.8 percent. Product sales amounted to 39.1 million (25.4) an increase of 54.2 percent. · Gross margin amounted to 39.2 percent (41,9). · Adjusted operating profit (EBIT) amounted to SEK -3.4 million (5.5) excluding restructuring costs of SEK 20.9 million corresponding to an operating margin of -1.9 percent (4.0). In addition, operating profit has been charged with non-recurring costs of SEK 6.9 million.

New number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, April 29[th], 2022, Moberg Pharma AB (OMX: MOB) announced that the total number of common shares in the company has increased to 46,681,123 due to the completion of the previously announced exercise of warrants of series 2020:1.During April 2022, the total number of shares and votes in the company has increased by 1,169,698, corresponding to 1,169,698 votes. As per April 29[th], 2022, the last trading day in April, the total number of shares in Moberg Pharma AB (publ) amounts to 46,681,123. All shares are common shares. The total number of votes are 46,681,123. At the date of

Sweden's first marketplace for NFTs Roya Edition just launched

Today, Sweden's first marketplace for NFTs, Roya Edition, launched. The marketplace is a niche platform for digital art, sound and photography within the lifestyle segment. The platform is based on Swedish values and wants to engage both consumers and brands that are interested in Web3.Roya Edition, a new marketplace for NFTs, launched today. NFTs, or Non-Fungible Tokens, are a certificate of ownership of a unique digital asset uploaded to the blockchain. “Roya Edition is a marketplace for everyone who is curious about the possibilities with web3. We want to help democratize culture and

Recipharm offers services to enable switch to next generation pMDI propellants

Global contract development and manufacturing organisation (CDMO) Recipharm, today announces that it is expanding its pMDI product development expertise to accommodate the increasing demand from pharmaceutical companies as they begin the transition to the next generation of propellants over the coming years. These new propellant gases have 90% to 99.9% lower global warming potential (GWP) than HFA134a. Jean-François Hilaire, Head of the Advanced Delivery Systems business unit at Recipharm, said: “We are committed to decarbonisation and helping our customers meet their sustainability

Tecnotree Corporation Interim Report 1[st] Jan – 31[st] Mar 2022 (unaudited)

Tecnotree Corporation Stock Exchange Release 29 April 2022 at 9.00 EETHIGH ORDER BOOK POSITION First quarter (1[st] Jan – 31[st] Mar 2022) · Net sales were EUR 13.3 (11.2) million. · Operating result was EUR 2.0 (3.1) million. · Net result was EUR 1.0 (2.4) million. · Order book at the end of the period stood at EUR 64.0 (47.3) million. · Cash flow after investments was EUR -2.1 (1.7) million. · Earnings per share were EUR 0.00 (0.01). Key figures, MEUR 1-3/2022 1-3/2021 1-12/2021Net sales 13.3 11.2 64.2

Quant AB (publ) publishes Annual Report and Sustainability Report for 2021

Quant’s Annual Report and Sustainability Report for 2021 have been published and are now available on the Quant website. For more information, please visit the Investors section on www.quantservice.com/investorStockholm, 29 April 2022 Quant AB (publ)  For further information, please contact: André Strömgren, CFO: +46 708 410 796 E-mail: ir@quantservice.com Quant AB (publ) is a global leader in industrial maintenance. For over 30 years, we have been realizing the full potential of maintenance for our customers. From embedding superior safety practices and building a true

Interim Report Q1 2022

Press release Sundsvall, April 29, 2022 Interim Report Q1 2022     January–March 2022 compared with January–March 2021 · Net sales amounted to SEK 5,015m (4,172). The increase was mainly attributable to higher selling prices in all product areas. · EBITDA improved 92% to SEK 2,608m (1,359). The increase was mainly attributable to higher selling prices in all product areas. Strong control of the value chain, with a high degree of self-sufficiency in wood, energy and logistics, enabled good cost control and thereby a significant increase in EBITDA margin to 52.0% (32.6).

JM acquires properties for residential development in Huddinge, Stockholm

JM has acquired five properties and signed a conditional agreement for an additional two properties in the Segeltorp industrial zone of Huddinge municipality. The properties are estimated to have the possibility of developing approximately 600 residential units in a future detailed plan. The acquisition of the five properties amounts to approximately SEK 270m, with payment in the second quarter of 2022.The acquired properties consist of office and business premises comprising around 7,000 square meters of rentable space. The transactions are reported as acquisitions of development

SRBNK: The shares in SpareBank 1 SR-Bank ASA will be quoted ex-dividend today

The shares in SpareBank 1 SR-Bank ASA will be quoted ex-dividend on 29 April 2022. A dividend of NOK 6.00 per share will be distributed on 6 May 2022 to registered shareholders as at 28 April 2022. Stavanger, 29 April 2022Contact people:Stian Helgøy, Vice President Investor Relations, Tel. +47 906 52 173 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Annual General Meeting – election to the Board of Directors

The Annual General Meeting of SpareBank 1 SR-Bank ASA reelected on 28 April 2022 Dag Mejdell as Chair and Trine Sæther Romuld as board member with a term of office of up to two years. The Annual General Meeting elected Camilla AC Tepfers and Kjetil Skjæveland as new board members with at term of office of up to two years. The Board of Directors of SpareBank 1 SR-Bank ASA has now the following composition: Dag Mejdell, chair Kate Henriksen, board member Jan Skogseth, board member Trine Sæther Romuld, board member Camilla AC Tepfers, board member Kjetil Skjæveland, board

SRBNK: Key information relating to the cash dividend

The Board of Directors of SpareBank 1 SR-Bank ASA has decided to distribute a cash dividend of NOK 6.0 per share for the accounting year of 2021. Dividend amount: 6.00 per share Declared currency: Norwegian krone Last day including right: 28 April 2022 Ex-date: 29 April 2022 Record date: 2 May 2022 Payment date: From 6 May 2022 Date of approval: 28 April 2022 This information is published in accordance with the requirements of the Continuing Obligations. Stavanger, 29 April 2022Contact people:Stian Helgøy, Vice President Investor Relations, Tel. +47 906 52 173

Semcon Interim Report January-March 2022

Continued strong growth and profitability.First quarter  · Net sales of SEK 495 million (418), up 18.2%  · The operating profit excluding non-recurring costs related to the separation project amounted to SEK 65 million (46), yielding an operating margin of 13.2% (11.0) · The operating profit amounted to SEK 62 million (46), yielding an operating margin of 12.6% (11.0) · Profit after tax amounted to SEK 47 million (34)  · Earnings per share (EPS) after dilution amounted to SEK 2.65 (1.96) · Net cash excluding lease liabilities amounted to SEK 235 million (259) Comment

Neste's Interim Report for January–March 2022

Neste Corporation, Interim Report, 29 April 2022 at 9 a.m. (EET) Strong financial performance amid markets impacted by the Ukraine war First quarter in brief: · Comparable EBITDA totaled EUR 578 million (EUR 429 million) · EBITDA totaled EUR 916 million (EUR 585 million) · Renewable Products' comparable sales margin was USD 806/ton (USD 699/ton) · Oil Products' total refining margin was USD 10.3/bbl (USD 6.7/bbl) · Cash flow before financing activities was EUR -960 million (EUR -645 million) · Return on average capital employed (ROACE)* was 19.1% over the last 12

Peab company builds frame for rental apartment buildings in Upplands Väsby

Smidmek AB, a company in the Peab Group, has been commissioned to deliver and mount frames for two new apartment blocks with 160 rental apartments in Upplands Väsby. The customer is the public housing company Väsbyhem AB and the contract is worth SEK 101 million.Smidmek, which delivers prefabricated concrete and steel frames all over Sweden, will further grow with another key deal in eastern Sweden. In the new project Smidmek shares the contract with housing company Väsbyhem. In total Smidmek will deliver 6,000 m2 double wall, 14,000 m2 flat slab and 9,500 m2 facade to the project. “Peab

Gösta Lundgren appointed as interim CEO of NAXS AB (publ)

The board of directors of NAXS AB (publ) announces that, effective immediately, Gösta Lundgren, CFO of the company, has been appointed as interim CEO of NAXS AB and will thereby replace the current CEO, Lennart Svantesson, who announced his resignation on 29 October 2021. Gösta Lundgren has been the CFO since the company’s inception in 2007. The board of NAXS AB looks forward to continuing its close work with Gösta and wishes to express its gratitude and best wishes to Lennart for his long history of service to the company. Contact information Gösta Lundgren, interim CEO Phone:

Navamedic: Annual report 2021

Oslo, 29 April 2022 - Navamedic ASA (OSE: NAVA) publishes its annual report for 2021. The report is attached and available on navamedic.com/investors. Additionally, the company's Annual Report in European Single Electronic Format (ESEF) is attached, please refer to the zip-file. For further information, please contact: Kathrine Gamborg Andreassen, CEO, Navamedic Mobile: +47 951 78 680 E-mail: kathrine@navamedic.com Lars Hjarrand, CFO, Navamedic Mobile: +47 917 62 842 E-mail: lars.hjarrand@navamedic.com Navamedic ASA is a Nordic pharma company and reliable provider of high-

YIT’s Interim report January-March 2022

YIT Corporation Stock exchange release 29 April 2022 at 9.00 a.m.YIT’s Interim report January-March 2022 Solid quarter driven by strong performance in Housing. · Adjusted operating profit increased to EUR 22 million (15). · Adjusted operating profit margin improved to 4.2% (2.7). · Housing continued its strong performance. · In Business Premises and Infrastructure, transformation progressed according to plan. · Result for the period, including discontinued operations, was EUR -133 million (4), negatively impacted by an impairment of EUR 152 million following the held for

There are no items matching the current filter
There are no more items matching the current filter
Back to top